MAGE-B3 Inhibitors
Chemical inhibitors of MAGE-B3 function primarily as histone deacetylase (HDAC) inhibitors. These inhibitors, including Trichostatin A, SAHA (Vorinostat), Romidepsin, Entinostat, Panobinostat, Valproic Acid, MS-275 (Entinostat), Belinostat, Chidamide, AR-42, Quisinostat, and CUDC-101, operate at the epigenetic level by reversing the acetylation status of histones and other proteins. This action can lead to the modulation of gene expression, ultimately affecting the transcriptional activity of genes that regulate the expression and function of MAGE-B3. For example, Trichostatin A and SAHA can upregulate tumor suppressor genes that are involved in the same pathways as MAGE-B3, while Panobinostat's broader inhibition of HDACs can lead to widespread changes in gene expression, including those regulating MAGE-B3.
The alteration of gene expression by HDAC inhibitors can influence the cellular environment in which MAGE-B3 operates. MS-275 and Belinostat, both being benzamide-based inhibitors, selectively inhibit Class I HDACs, thereby affecting the chromatin structure and gene transcription in a manner that can alter the activity of MAGE-B3. Similarly, Chidamide's and AR-42's inhibitory actions on HDACs result in changes to the transcriptional regulation of genes, which can impact the function of MAGE-B3 within cells. CUDC-101, while also an HDAC inhibitor, additionally targets other proteins such as EGFR and HER2, which can lead to a multifaceted alteration in protein interactions and gene regulation, thereby influencing the functional role of MAGE-B3. These chemical inhibitors, through their interaction with HDACs, can change the expression patterns of genes and proteins that are crucial for the function of MAGE-B3.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can upregulate the expression of tumor suppressor genes and thereby suppress the function of proteins involved in tumor growth and survival pathways, including MAGE-B3. By altering the acetylation status of histones and other proteins, it can change the transcriptional activity of genes that regulate MAGE-B3 indirectly inhibiting its function. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA (Vorinostat) is another histone deacetylase inhibitor which functions similarly to Trichostatin A. It can affect the expression of genes that control the activity of cancer-related proteins, potentially inhibiting MAGE-B3's role in oncogenic processes. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin works as a histone deacetylase inhibitor, leading to increased acetylation of histones and non-histone proteins which could suppress oncogenic protein functions, potentially including MAGE-B3. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Entinostat selectively inhibits Class I histone deacetylases, leading to epigenetic modifications that may result in the suppression of oncogenic proteins, potentially inhibiting the function of MAGE-B3. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
As a pan-histone deacetylase inhibitor, Panobinostat induces hyperacetylation of histones, potentially altering the expression of genes involved in cancer cell survival and proliferation, indirectly inhibiting MAGE-B3 function. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid, while primarily used as an anticonvulsant, also acts as a histone deacetylase inhibitor, which can alter gene expression and potentially inhibit the function of proteins like MAGE-B3 involved in cancer progression. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
Belinostat is a histone deacetylase inhibitor that affects gene expression and has the potential to inhibit the function of cancer-associated proteins, including MAGE-B3, by altering epigenetic regulation. | ||||||
Chidamide | 743420-02-2 | sc-364462 sc-364462A sc-364462B | 1 mg 5 mg 25 mg | $62.00 $250.00 $1196.00 | ||
Chidamide is a benzamide chemical that inhibits histone deacetylase, leading to changes in gene expression and potential inhibition of proteins like MAGE-B3 involved in tumorigenesis. | ||||||
(S)-HDAC-42 | 935881-37-1 | sc-296364 sc-296364A | 1 mg 5 mg | $96.00 $417.00 | ||
AR-42 is a histone deacetylase inhibitor that can modulate gene expression patterns, potentially leading to the functional inhibition of proteins involved in cancer pathways, including MAGE-B3. | ||||||
JNJ-26481585 | 875320-29-9 | sc-364515 sc-364515A | 5 mg 50 mg | $321.00 $1224.00 | ||
Quisinostat is a potent histone deacetylase inhibitor that could indirectly inhibit the function of MAGE-B3 by altering the expression of genes that regulate oncogenic pathways. | ||||||